You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

TYLENOL W Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Tylenol W, and what generic alternatives are available?

Tylenol W is a drug marketed by Ortho Mcneil Pharm and Janssen Pharms and is included in five NDAs.

The generic ingredient in TYLENOL W is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tylenol W

A generic version of TYLENOL W was approved as acetaminophen; codeine phosphate by WES PHARMA INC on June 27^th, 2019.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for TYLENOL W?
What are the global sales for TYLENOL W?
What is Average Wholesale Price for TYLENOL W?

Summary for TYLENOL W

US Patents:	0
Applicants:	2
NDAs:	5
DailyMed Link:	TYLENOL W at DailyMed

Drug patent expirations by year for TYLENOL W

US Patents and Regulatory Information for TYLENOL W

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ortho Mcneil Pharm	TYLENOL W/ CODEINE	acetaminophen; codeine phosphate	SOLUTION;ORAL	085057-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Janssen Pharms	TYLENOL W/ CODEINE NO. 2	acetaminophen; codeine phosphate	TABLET;ORAL	085055-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ortho Mcneil Pharm	TYLENOL W/ CODEINE	acetaminophen; codeine phosphate	TABLET;ORAL	085056-003	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.